Clinical Trials on Neuromuscular Blockade in Australia

Total 288 results

Merck Sharp & Dohme LLC

Completed

Efficacy, Safety, and Pharmacokinetics of Sugammadex for Reversal of Neuromuscular Blockade (NMB) in Pediatric Participants (MK-8616-089)

Neuromuscular Blockade

United States, Austria, Belgium, Denmark, Finland, Germany, Spain, Turkey
Merck Sharp & Dohme LLC

Completed

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

Neuromuscular Blockade

United States, Australia, Belgium, Brazil, Denmark, Finland, France, Guatemala, Hungary, Malaysia, Mexico, Netherlands, Peru, Russian Federation
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety of Sugammadex Dosed According to Actual Body Weight (ABW) or Ideal Body Weight (IBW) in Reversal of Neuromuscular Blockade (NMB) in Morbidly Obese Participants (MK-8616-146)

Neuromuscular Blockade

United States, Austria, Belgium, Denmark, Germany
Merck Sharp & Dohme LLC

Completed

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

Reversal of Neuromuscular Blockade

United States, Austria, Denmark, Germany
Lateral Pharma Pty Ltd
Southern Star Research Pty Ltd.

Completed

A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain

Radiculopathy Lumbar

Australia
Biogen

Completed

Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants

Sciatica

Australia
University of Melbourne
Melbourne Health; National University Hospital, Singapore; Flinders Medical Centre and other collaborators

Completed

Physical Function in Critical Care (PaciFIC) (PaciFIC)

Intensive Care (ICU) Myopathy

Singapore, Australia, Brazil
SIMR (Australia) Biotech Pty Ltd.

Completed

A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419

Peripheral Neuropathic Pain

Australia
University of Adelaide

Unknown

Minocycline for the Prevention of Post-operative Intercostal Neuralgia

Post-operative Intercostal Neuralgia

Australia
Abcuro, Inc.

Active, not recruiting

A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM)

Inclusion Body Myositis

Australia
Actinogen Medical
ICON plc

Completed

Xanamem™ in Healthy Elderly Subjects (XanaHES)

Cognitive Function | Peripheral Neuropathy | Electrocardiography | Central Nervous System | Safety | Healthy Ageing | Cortisol | Cerebrospinal Fluid | Small Fibre Neuropathy

Australia
Sonnet BioTherapeutics

Terminated

SON-080 in Patients With Persistent Chemotherapy-induced Peripheral Neuropathy (CIPN)

Chemotherapy-induced Peripheral Neuropathy (CIPN)

Australia
iN Therapeutics Co., Ltd.

Recruiting

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

Pain | Osteoarthritis | Chronic Pain | Neuropathic Pain | Post Herpetic Neuralgia

Australia
ResMed
The University of Western Australia; Sir Charles Gairdner Hospital

Terminated

Juno Perth Clinical Trial

Respiratory Insufficiency | Chronic Obstructive Pulmonary Disease (COPD) | Obesity Hypoventilation Syndrome | Neuromuscular Disease | Upper Airway Obstruction

Australia
Women's and Children's Hospital, Australia
Allergan Australia Pty Ltd

Unknown

Exploring Hypertonia in Children With Cerebral Palsy (HypE-CP)

Cerebral Palsy.

Australia
Xalud Therapeutics, Inc.

Terminated

Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain

Neuropathic Pain

Australia
Austin Health

Unknown

Neuraxial Pethidine After Lumbar Surgery Trial

Sciatica

Australia
Deakin University

Completed

Efficacy of S-Adenosylmethionine in Fibromyalgia

Fibromyalgia Syndrome

Australia
University of Kansas Medical Center
The Perron Institute

Recruiting

Phase III Trial of Sirolimus in IBM

Inclusion Body Myositis

United States, Australia
KAI Pharmaceuticals
Trident Clinical Research Pty Ltd

Completed

Safety and Efficacy Study of KAI-1678 to Treat Pain in Subjects With Postherpetic Neuralgia

Postherpetic Neuralgia

Australia
SpineThera Australia PTY LTD

Terminated

Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain (SALIENT)

Lumbar Radiculopathy

Australia
St George Hospital, Australia
St George & Sutherland Medical Research Foundation

Unknown

A Comparative Effectiveness Randomised Placebo Controlled Pilot Trial of the Management of Acute Lumbar Radicular Pain (SCIATICA)

Acute Sciatica

Australia
Allergan

Terminated

Safety and Efficacy of AGN201781 in Neuropathic Pain

Neuralgia

Germany, Australia
Theradaptive, Inc

Recruiting

OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion (OASIS)

Lumbar Disc Herniation | Degenerative Disc Disease | Lumbar Spinal Stenosis | Spinal Stenosis | Lumbar Spondylolisthesis | Lumbar Radiculopathy | Lumbar Disc Disease | Spine Disease | Lumbar Spine Degeneration | Degenerative Spondylolisthesis

Australia
Avigen

Completed

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of AV411 in Neuropathic Pain

Diabetic Neuropathy

Australia
Murdoch Childrens Research Institute

Completed

Effect of Creatine Monohydrate on Functional Muscle Strength in Children With FSHD

Facio-Scapulo-Humeral Dystrophy | FSHD2 | FSHD1

Australia
CanSino Biologics Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

Poliomyelitis

Australia
Implicit Bioscience

Withdrawn

IC14 for Treatment of Amyotrophic Lateral Sclerosis

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Australia
Implicit Bioscience
Royal Brisbane and Women's Hospital

Completed

Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Australia
Implicit Bioscience

Withdrawn

IC14 for Rapidly Progressive Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Australia
The Florey Institute of Neuroscience and Mental...
The University of Queensland; Mobius Medical Pty Ltd.

Recruiting

A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS (AMBALS)

Amyotrophic Lateral Sclerosis

Australia
The Alfred

Completed

Acute Skeletal Muscle Wasting and Relation to Physical Function in Patients Requiring ECMO

Critical Illness | Extracorporeal Membrane Oxygenation | Muscle Wasting

Australia
Medical University of Vienna
Department of Surgery, Social Medical Centre South, Vienna, Austria; Institute...

Completed

Randomized, Controlled Study to Investigate the Effect of Neuromuscular Electrical Stimulation (NMES) on Muscle Metabolism of Abdominal Surgical Patients

Muscular Atrophy

Austria
Vienna Hospital Association

Completed

High Tone Therapy for Chemotherapy Induced Neuropathy

Electrical Stimulation | Chemotherapy-induced Peripheral Neuropathy

Austria
Medical University of Vienna

Completed

Central Programming in Patients With a Bionic Hand After Traumatic Brachial Plexus Injury

Brachial Plexus Neuropathies | Traumatic Brachial Plexus Lesion | Bionic Hand Reconstruction

Austria
Medical University of Vienna

Completed

Adherence to Blood Pressure Diaries With Personalized Visuals

Neurovascular Disorder

Austria
Kirsten Elwischger, MD

Completed

DTI Study of the Influence of Physiotherapy on Distribution of BoNT in Spastic Muscle

Spasticity

Austria
Medical University of Vienna
Vienna General Hospital; WWTF, Wiener Wissenschafts-, Forschungs- und Technologiefonds

Unknown

Effect of Opioids in Neuropathic Pain in Postherpetic Patients (VHPRG-HDRPH)

Neuralgia, Postherpetic

Austria
Spinogenix
Novotech (Australia) Pty Limited

Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPG302 in Healthy Volunteers and ALS Participants

Amyotrophic Lateral Sclerosis

Australia
Vienna Hospital Association

Recruiting

The Mamma HiToP Study

Chemotherapy-induced Peripheral Neuropathy

Austria
Gold Coast Hospital and Health Service
Bod Australia

Active, not recruiting

EMERALD TRIAL Open Label Extension Study (EMERALD-OLE)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Cannabis | CBD

Australia
Collaborative Medicinal Development Pty Limited

Unknown

CuATSM Compared With Placebo for Treatment of ALS/MND

Amyotrophic Lateral Sclerosis

Australia
Collaborative Medicinal Development Pty Limited

Active, not recruiting

ALS Treatment Extension Study

Amyotrophic Lateral Sclerosis

Australia
Gold Coast Hospital and Health Service
Bod Australia

Active, not recruiting

Efficacy of Cannabinoids in Amyotrophic Lateral Sclerosis or Motor Neurone Disease

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Australia
Hugo W. Moser Research Institute at Kennedy Krieger...
Concord Hospital; FSHD Global Research Foundation

Completed

Bone Health in Facioscapulohumeral Muscular Dystrophy (FSHD)

Facioscapulohumeral Muscular Dystrophy

United States, Australia
Shanghai SIMR Biotechnology Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN)

Postherpetic Neuralgia

China, Australia
Ludwig Boltzmann Gesellschaft

Recruiting

Extracorporal Shock Wave Treatment to Improve Nerve Regeneration

Peripheral Nerve Injury

Austria
Clene Nanomedicine
Clene Australia Pty Ltd

Completed

Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS) (RESCUE-ALS)

Amyotrophic Lateral Sclerosis

Australia
PharmAust Ltd
Macquarie University, Australia; Calvary Health Care Bethlehem

Recruiting

An Open Label Extension Study of Monepantel in Individuals With Motor Neurone Disease

Motor Neuron Disease

Australia
PharmAust Ltd
Macquarie University, Australia; FightMND; Calvary Health Care Bethlehem

Completed

A Study of Monepantel in Individuals With Motor Neurone Disease

Motor Neuron Disease

Australia

Clinical Trials on Neuromuscular Blockade in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations